IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q2 2017 Holdings

Filed 2017-08-14 | 15 holdings | $142.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Irhythm Technologies Inc(IRTC)COM450056106$28.3K665,96519.9%
Versartis IncCOM92529L102$25.3K1,448,29617.8%
Edge Therapeutics IncCOM279870109$24.1K2,344,86816.9%
Oxford Immunotec Global PLCORD SHSG6855A103$16.0K952,49711.3%
Wave Life Sciences LTD(WVE)SHSY95308105$12.2K658,2598.6%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$8.5K527,7305.9%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$6.9K3,090,6734.8%
Sage Therapeutics Inc(SG7)COM78667J108$5.4K67,8723.8%
Sierra Oncology IncCOM82640U107$3.2K2,744,0882.3%
Dimension Therapeutics IncCOM25433V105$3.0K2,059,2832.1%
Otonomy IncCOM68906L105$2.1K109,8251.5%
Obseva SACOMH5861P103$2.0K230,2051.4%
Alder Biopharmaceuticals Inc(ALDR1EUR)COM014339105$2.0K171,3641.4%
Dermira Inc(DERMEUR)COM24983L104$1.8K61,1091.3%
Trillium Therapeutics IncCOM89620X506$1.8K404,1591.2%